Worldwide epidemiology of HBV infection, disease burden, and vaccine prevention (Q36388315)

13 August 2017

1 reference

title

Worldwide epidemiology of HBV infection, disease burden, and vaccine prevention (English)

1 reference

13 August 2017

1 reference

1 reference

1 reference

Lavanchy D

1

1 reference

13 August 2017

1 December 2005

1 reference

Journal of Clinical Virology

13 August 2017

1 reference

13 August 2017

34 Suppl 1

1 reference

13 August 2017

S1-3

1 reference

Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group

13 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2900384-7

7 January 2021

The prevalence of hepatitis B and C infections among immigrants to a newly reclaimed area endemic for Schistosoma mansoni in Sinai, Egypt

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2900384-7

7 January 2021

Rising incidence of hepatocellular carcinoma in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2900384-7

7 January 2021

Hepatitis B virus infection in native versus immigrant or adopted children in Italy following the compulsory vaccination.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2900384-7

7 January 2021

Hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2900384-7

7 January 2021

The 20th United States-Japan Joint Hepatitis Panel Meeting

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2900384-7

7 January 2021

Hepatitis B virus infection in children and adolescents in a hyperendemic area: 15 years after mass hepatitis B vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2900384-7

7 January 2021

Estimating the world cancer burden: Globocan 2000.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2900384-7

7 January 2021

The impact of the hepatitis B mass immunisation campaign on the incidence and risk factors of acute hepatitis B in Italy

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2900384-7

7 January 2021

Cost-effectiveness of interferon-alpha 2b treatment for hepatitis B e antigen-positive chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2900384-7

7 January 2021

Economic evaluation of the societal costs of hepatitis B in South Korea.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2900384-7

7 January 2021

Epidemiology of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2900384-7

7 January 2021

10.1016/S1386-6532(05)00384-7

Identifiers

DOI

1 reference

13 August 2017

1 reference

PubMed ID

16461208